Mental stress as consequence and cause of vision loss: the dawn of psychosomatic ophthalmology for preventive and personalized medicine

Bernhard A Sabel, Jiaqi Wang, Lizbeth Cárdenas-Morales, Muneeb Faiq, Christine Heim, Bernhard A Sabel, Jiaqi Wang, Lizbeth Cárdenas-Morales, Muneeb Faiq, Christine Heim

Abstract

The loss of vision after damage to the retina, optic nerve, or brain has often grave consequences in everyday life such as problems with recognizing faces, reading, or mobility. Because vision loss is considered to be irreversible and often progressive, patients experience continuous mental stress due to worries, anxiety, or fear with secondary consequences such as depression and social isolation. While prolonged mental stress is clearly a consequence of vision loss, it may also aggravate the situation. In fact, continuous stress and elevated cortisol levels negatively impact the eye and brain due to autonomous nervous system (sympathetic) imbalance and vascular dysregulation; hence stress may also be one of the major causes of visual system diseases such as glaucoma and optic neuropathy. Although stress is a known risk factor, its causal role in the development or progression of certain visual system disorders is not widely appreciated. This review of the literature discusses the relationship of stress and ophthalmological diseases. We conclude that stress is both consequence and cause of vision loss. This creates a vicious cycle of a downward spiral, in which initial vision loss creates stress which further accelerates vision loss, creating even more stress and so forth. This new psychosomatic perspective has several implications for clinical practice. Firstly, stress reduction and relaxation techniques (e.g., meditation, autogenic training, stress management training, and psychotherapy to learn to cope) should be recommended not only as complementary to traditional treatments of vision loss but possibly as preventive means to reduce progression of vision loss. Secondly, doctors should try their best to inculcate positivity and optimism in their patients while giving them the information the patients are entitled to, especially regarding the important value of stress reduction. In this way, the vicious cycle could be interrupted. More clinical studies are now needed to confirm the causal role of stress in different low vision diseases to evaluate the efficacy of different anti-stress therapies for preventing progression and improving vision recovery and restoration in randomized trials as a foundation of psychosomatic ophthalmology.

Keywords: Low vision; Personalized medicine; Predictive; Preventive; Psychology; Psychosomatic medicine; Relaxation; Restoration; Stress.

Conflict of interest statement

Compliance with ethical standardsB. Sabel is co-owner of a private medical practice (www.savir-center.com) where the two patients described in this paper were treated.For this type of study, formal consent is not required. We thank our patients for their consent to publish their case histories.

Figures

Fig. 1
Fig. 1
Causes of vision loss taken from “SUSRUTA SAMHITA“[10], first chapter of “BASICS OF EYE DISEASES.” The figure shows the original Sanskrit text passage with its transformation to Roman lettering and the respective English translation. Six causes of vision loss (printed here in bold) are related to emotional stress: 1. USNABHITAPTASYA JALAPRAVESHATH—Drinking or exposing to cool water after exposing to heat. 2. DOOREKSHANATH—Looking at the very distant objects regularly for a long time, may be without blinking. 3. SWAPNA VIPARYAASCHA— Improper sleeping habits like daytime sleeping, awakening at night etc. 4. PRASAKTA SAMRODHANA—Continuous weeping. 5. KOPA Excessive anger. 6. SHOKAGrief. 7. KLESHA Stress: suffering pain, physical, and mental exhaustion. 8. ABIGHAATA—Minute irritative injuries or contusion injuries or perforating injuries. 9. ATI MAITHUNNA—Indulgence in excessive sexual intercourse. 10. SHUKTHA ARANALA AMLA—Vinegar and alcoholic beverages. 11. KULUTTA—Intake of horse gram excessively. 12. MASHA—Intake of black gram excessively. 13. ATISWEDA—Excessive sweating. 14. DHOOMA NISEVANATH—Exposing to smoke or tobacco smoking. 15. CHARDHIR VIGHATATH—Suppressing the vomit. 16. VAMANATHI YOGATH—Excessively indulging in inducing vomiting. 17. BHASHPA GRAHATHSuppressing tears. 18. SUKSHMA NIREEKSHANATH—Observing the minute things or seeing too tiny objects
Fig. 2
Fig. 2
Diagram of stressors (chronic or acute) and their effects showing the vicious cycle of mental stress and vision loss and the cause-effect relationship of stress and vision loss. According to this concept, low vision is both cause and consequence of vision loss. Note: the disease is involving different levels of analysis, psychological, biological, and pathological (ophthalmological)
Fig. 3
Fig. 3
Humphrey visual fields of a 78-year-old woman with stress-induced vision loss OD before vs. after a 10-day treatment. Treatment included alternating current stimulation plus relaxation exercises and psychological consulting. In both tests, she had neither any fixation loss nor any false positive responses. Visual field index improved from 12 to 21% (pre/post mean deviation: − 25.97/− 22.44 dB). Subjectively, the patients reported improvement from “gray” to “white” vision with noticeably better acuity. She did not notice any changes in the central visual field but could better recognize faces and street signs, and she was able to see her hair in the mirror again, with her upper visual field. The second case is also a woman who was treated for her glaucoma with current stimulation and various anti-stress methods such as psychological consulting and relaxation (see text for further details)
Fig. 4
Fig. 4
Cartoon displaying how the patient feels when confronted with a negative prognosis

References

    1. WHO. Visual impairment and blindness. 2014.
    1. Kempen GIJM, Ballemans J, Ranchor AV, et al. The impact of low vision on activities of daily living, symptoms of depression, feelings of anxiety and social support in community-living oder adults seeking vision rehabilitation services. Qual Life Res. 2012;21:1405–1411.
    1. Sabel BA, Fedorov A, Henrich-Noack P, Gall C. Vision restoration after brain damage: the “residual vision activation theory”. Prog Brain Res. 2010;192:199–262.
    1. Kasten E, Wüst S, Behrens-Baumann W, et al. Computer-based training for the treatment of partial blindness. Nat Med. 1998;4:1083–1087.
    1. Sabel BA, Gudlin J. Vision restoration training for Glaucoma. A randomized clinical trial. JAMA Ophthalmology. 2014;132:381–389.
    1. Fedorov A, Jobke S, Bersnev V, Chibisova A, Chibisova Y, Gall C, et al. Restoration of vision after optic nerve lesions with noninvasive transorbital alternating current stimulation: a clinical observation study. Brain Stimul. 2011;4:189–201.
    1. Gall C, Sgorzaly S, Schmidt S, Brandt S, Fedorov A, Sabel BA. Noninvasive transorbital alternating current stimulation improves subjective visual functioning and vision-related quality of life in optic neuropathy. Brain Stimul. 2011;4:175–88.
    1. Sabel BA, Fedorov AB, Naue N, Borrmann A, Herrmann C, Gall C. Non-invasive alternating current stimulation improves vision in optic neuropathy. Restor Neurol Neurosci. 2011;29:497–510.
    1. Bola M, Gall C, Moewes C, Fedorov A, Hinrichs H, Sabel BA. Brain functional connectivity network breakdown and restoration in blindness. Neurology. 2014;83:542–551.
    1. Susruta (1.300 BC). “Susruta Samhita”. Krishnadas Academy, Varanasi, India. 1998.
    1. Flammer J, Konieczka K. The discovery of the Flammer syndrome: a historical and personal perspective. EPMA J. 2017;8:75–97.
    1. Konieczka K, Ritch R, Traverso CE, et al. Flammer syndrome. EPMA J. 2014;5:11.
    1. Fernald LD. Psychology: six perspectives. Thousand Oaks, CA: Sage Publications. 2008:12–5.
    1. Folkman S. Stress: appraisal and coping. Encyclopedia of behavioral medicine. Springer. N Y. 2013:1913–5.
    1. Shindler KS, Galetta SL, Volpe NJ. Functional visual loss. Curr Treat Options Neurol. 2004;6:67–73.
    1. Faiq MA, Dada R, Kumar A, et al. Brain: the potential diagnostic and therapeutic target for glaucoma. CNS Neurological Disorders Drug Targets. 2016;15:839–844.
    1. Gupta N, Yücel YH. Glaucoma as a neurodegenerative disease. Curr Opin Ophthalmol. 2007;18:110–114.
    1. Gupta N, Ang LC, De Tilly LN, et al. Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex. Br J Ophthalmol. 2006;90:674–678.
    1. Gupta N, Yücel YH. What changes can we expect in the brain of glaucoma patients? Surv Ophthalmol. 2007;52:S122–S126.
    1. Wang J, Li T, Sabel BA, et al. Structural brain alterations in primary open angle glaucoma: a 3T MRI study. Sci Rep. 2016;6:18969.
    1. Konieczka K, Choi HJ, Koch S, et al. Relationship between normal tension glaucoma and Flammer syndrome. EPMA J. 2017;8:111–117.
    1. Flammer J, Haefliger IO, Orgül S, et al. Vascular dysregulation: a principal risk factor for glaucomatous damage? J Glaucoma. 1999;8:212–219.
    1. Grieshaber MC, Mozaffarieh M, Flammer J. What is the link between vascular dysregulation and glaucoma? Surv Ophthalmol. 2007;52:S144–S154.
    1. Bojinova RI, Konieczka K, Todorova MG. Unilateral loss of vision after spinal surgery in a patient with Flammer syndrome. Klin Monatsbl Augenheilkd. 2016;233:429–431.
    1. Sabel BA. “Restoring Low Vision”. Amazon, 2016;241pp.
    1. Rozanski C, Haythornthwaite JA, Dagnelie G, et al. Applying theories and interventions from behavioral medicine to understand and reduce visual field variability in patients with vision loss. Med Hypotheses. 2014;83:190–195.
    1. Olawoye O, Teng CC, Shabto U, et al. Visual recovery in a patient with total hyphema, neovascular glaucoma, long-standing retinal detachment and no light perception vision: a case report. J Med Case Rep. 2011;5:221.
    1. Cannon WB. Bodily changes in pain, hunger, fear and rage. Oxford: Appleton; 1929.
    1. Ulrich-Lai YM, Herman JP. Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci. 2009;10:397–409.
    1. Heim C, Newport DJ, Heit S, et al. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. J Am Med Assoc. 2000;284:592–597.
    1. Atzori M, Cuevas-Olguin R, Esquivel-Rendon E, et al. Locus ceruleus norepinephrine release: a central regulator of CNS spatio-temporal activation? Front Synaptic Neurosci. 2016;8:25.
    1. Cohen S, Janicki-Deverts D, Doyle WJ, et al. Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proc Natl Acad Sci. 2012;109:5995–5999.
    1. McKlveen JM, Myers B, Flak JN, et al. Role of prefrontal cortex glucocorticoid receptors in stress and emotion. Biol Psychiatry. 2013;74:672–679.
    1. Lupien SJ, McEwen BS, Gunnar MR, et al. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci. 2009;10:434–445.
    1. Heim C, Ehlert U, Hellhammer DH. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology. 2000;25:1–35.
    1. Raison CL, Miller AH. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatr. 2003;160:1554–1565.
    1. Roozendaal B, Koolhaas JM, Bohus B. Differential effect of lesioning of the central amygdala on the bradycardiac and behavioral response of the rat in relation to conditioned social and solitary stress. Behav Brain Res. 1990;41:39–48.
    1. Roozendaal B, Koolhaas JM, Bohus B. Central amygdala lesions affect behavioral and autonomic balance during stress in rats. Physiol Behav. 1991;50:777–781.
    1. Bhatnagar S, Vining C, Denski KAI. Regulation of chronic stress-induced changes in hypothalamic-pituitary-adrenal activity by the basolateral amygdala. Ann N Y Acad Sci. 2004;1032:315–319.
    1. Dayas CV, Buller KM, Day TA. Neuroendocrine responses to an emotional stressor: evidence for involvement of the medial but not the central amygdala. Eur J Neurosci. 1999;11:2312–2322.
    1. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27:24–31.
    1. Segerstrom SC, Miller GE. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull. 2004;130:601–630.
    1. Madrigal JLM, Moro MA, Lizasoain I, et al. Stress-induced increase in extracellular sucrose space in rats is mediated by nitric oxide. Brain Res. 2002;938:87–91.
    1. O'Connor KA, Johnson JD, Hansen MK, et al. Peripheral and central proinflammatory cytokine response to a severe acute stressor. Brain Res. 2003;991:123–132.
    1. Maes M. Major depression and activation of the inflammatory response system. flammerCytokines, stress, and depression. Springer US. 1999;25–46.
    1. Leonard BE, Song C. Stress, depression, and the role of cytokines. Adv Exp Med Biol. 1999;461:251–65.
    1. Torriglia A, Valamanesh F, Behar-Cohen F. On the retinal toxicity of intraocular glucocorticoids. Biochem Pharmacol. 2010;80:1878–1886.
    1. Riccadonna M, Covi G, Pancera P, et al. Autonomic system activity and 24-hour blood pressure variations in subjects with normal-and high-tension glaucoma. J Glaucoma. 2003;12:156–163.
    1. Na KS, Lee NY, Park SH, et al. Autonomic dysfunction in normal tension glaucoma: the short-term heart rate variability analysis. J Glaucoma. 2010;19:377–381.
    1. Marc A, Stan C. Effect of physical and psychological stress on the course of primary open angle glaucoma. Oftalmologia (Bucharest, Romania: 1990) 2013;57:60–66.
    1. Stan C, Tirziu D, Lupaşcu S. A new risk factor in glaucoma? Oftalmologia (Bucharest, Romania: 1990). 2011;55:74–6.
    1. Sommer A. Ocular hypertension and normal-tension glaucoma: time for banishment and burial. Arch Ophthalmol. 2011;129:785–787.
    1. Flammer J, Konieczka K, Bruno RM, et al. The eye and the heart. Eur Heart J. 2013;34:1270–1278.
    1. Flammer J, Konieczka K, Flammer AJ. The primary vascular dysregulation syndrome: implications for eye diseases. EPMA J. 2013;4:14.
    1. Flammer J. Die glaukomatöse Optikusneuropathie: Ein Reperfusionsschaden. Klin Monatsbl Augenheilkd. 2001;218:290–291.
    1. Toda N, Nakanishi-Toda M. How mental stress affects endothelial function. Pflügers Archiv-Eur J Physiol. 2011;462:779–794.
    1. Kurysheva NI, Tomilova IK, Kadykova EL, et al. Nitrogen oxide in the pathogenesis of glaucoma and cataract. Vestn oftalmol. 2001;117:34–37.
    1. Schmetterer L, Polak K. Role of nitric oxide in the control of ocular blood flow. Prog Retin Eye Res. 2001;20:823–847.
    1. Kurysheva NI, Trubilin VN, Tsaregorodtseva MA, et al. Features autonomic nervous system cardiovascular system in patients with glaucoma normal pressure. Ophthalmology. 2012;9:44–48.
    1. Iwata M, Ota KT, Li XY, et al. Psychological stress activates the inflammasome via release of adenosine triphosphate and stimulation of the purinergic type 2X7 receptor. Biol Psychiatry. 2016;80:12–22.
    1. Shily BG. Psychophysiological stress, elevated intraocular pressure, and acute closed-angle glaucoma. Optom Vis Sci. 1987;64:866–870.
    1. Bali SJ, Parmar T, Arora V, et al. Evaluation of major depressive disorder in patients receiving chronic treatment with topical timolol. Ophthalmologica. 2011;226:157–160.
    1. Severn P, Fraser S, Finch T, et al. Which quality of life score is best for glaucoma patients and why? BMC Ophthalmol. 2008;8:2.
    1. De Leo D, Hickey PA, Meneghel G, et al. Blindness, fear of sight loss, and suicide. Psychosomatics. 1999;40:339–344.
    1. Nyman SR, Dibb B, Victor CR, et al. Emotional well-being and adjustment to vision loss in later life: a meta-synthesis of qualitative studies. Disabil Rehabil. 2012;34:971–981.
    1. Mozaffarieh M, Grieshaber MC, Flammer J. Oxygen and blood flow: players in the pathogenesis of glaucoma. Mol Vis. 2008;14:224.
    1. Flammer J, Orgül S, Costa VP, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 2002;21:359–393.
    1. Said SM, Albouaini K, Herold J, et al. Takotsubo syndrome from original description up to now. Medizinische Klinik (Munich, Germany: 1983) 2009;104:434–440.
    1. Konieczka K, Koch S, Schoetzau A, et al. Increased prevalence of Flammer syndrome in patients with retinitis pigmentosa. Klin Monatsbl Augenheilkd. 2016;233:448–452.
    1. Fang L, Baertschi M, Mozaffarieh M. The effect of flammer-syndrome on retinal venous pressure. BMC Ophthalmol. 2014;14:121.
    1. Flammer J, Konieczka K. Retinal venous pressure: the role of endothelin. EPMA J. 2015;6:21.
    1. Bojinova RI, Konieczka K, Meyer P, et al. The trilateral link between anaesthesia, perioperative visual loss and Flammer syndrome. BMC Anesthesiol. 2016;16:10.
    1. Konieczka K, Koch S, Binggeli T, et al. Multiple sclerosis and primary vascular dysregulation (Flammer syndrome) EPMA J. 2016;7:1–5.
    1. Bruce BB, Newman NJ. Functional visual loss. Neurol Clin. 2010;28:789–802.
    1. Lim SA, Siatkowski RM, Farris BK. Functional visual loss in adults and children patient characteristics, management, and outcomes. Ophthalmology. 2015;112:1821–1828.
    1. Odberg T, Jakobsen JE, Hultgren SJ, et al. The impact of glaucoma on the quality of life of patients in Norway. Acta Ophthalmol. 2001;79:116–120.
    1. Odberg T, Jakobsen JE, Hultgren SJ, et al. The impact of glaucoma on the quality of life of patients in Norway. II. Patient response correlated to objective data. Acta Ophthalmol Scand. 2001;79:121–124.
    1. Hamelin N, Blatrix C, Brion F, et al. How patients react when glaucoma is diagnosed? J Fr Ophtalmol. 2002;25:795–8.
    1. Bechetoille A, Arnould B, Bron A, et al. Measurement of health-related quality of life with glaucoma: validation of the Glau-QoL© 36-item questionnaire. Acta Ophthalmol. 2008;86:71–80.
    1. Bramley T, Peeples P, Walt JG, et al. Impact of vision loss on costs and outcomes in medicare beneficiaries with glaucoma. Arch Ophthalmol. 2008;126:849–856.
    1. Skalicky S, Goldberg I. Depression and quality of life in patients with glaucoma: a cross-sectional analysis using the Geriatric Depression Scale-15, assessment of function related to vision, and the Glaucoma Quality of Life-15. J Glaucoma. 2008;17:546–551.
    1. Kong X, Yan M, Sun X, et al. Anxiety and depression are more prevalent in primary angle closure glaucoma than in primary open-angle glaucoma. J Glaucoma. 2015;24:e57–e63.
    1. Mabuchi F, Yoshimura K, Kashiwagi K, et al. Risk factors for anxiety and depression in patients with glaucoma. Br J Ophthalmol. 2012;96:821–825.
    1. Diniz-Filho A, Abe RY, Cho HJ, et al. Fast visual field progression is associated with depressive symptoms in patients with glaucoma. Ophthalmology. 2016;123:754–759.
    1. Casten R, Edmonds S, Rovner B. The impact of depression in older adults with age-related macular degeneration. J Visual Impair Blindness. 2002;96:399–415.
    1. Williams RA, Brody BL, Thomas RG, et al. The psychosocial impact of macular degeneration. Arch Ophthalmol. 1998;116:514–520.
    1. Wahl HW, Schilling O, Becker S. Age-related macular degeneration and change in psychological control: role of time since diagnosis and functional ability. J Gerontol Ser B Psychol Sci Soc Sci. 2007;62:P90–P97.
    1. Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006;368:1795–1809.
    1. Strougo Z, Badoux A, Duchanel D. Psycho-affective problems associated with retinitis pigmentosa. J Fr Ophtalmol. 1996;20:111–6.
    1. Bittner AK, Ibrahim MA, Haythomthwaite JA, et al. Vision test variability in retinitis pigmentosa and psychosocial factors. Optom Vis Sci. 2011;88:1496.
    1. Hahm BJ, Shin YW, Shim EJ, et al. Depression and the vision-related quality of life in patients with retinitis pigmentosa. Br J Ophthalmol. 2008;92:650–654.
    1. Angi M, Rupolo G, De Bertolini C, et al. Personality, psychophysical stress and myopia progression. Graefes Arch Clin Exp Ophthalmol. 1993;231:136–140.
    1. Avetisov ES, Gundorova RA, Shakarian AA, et al. Effects of acute psychogenic stress on the state of several functions of the visual analyzer. Vestn oftalmol. 1991;107:17–19.
    1. Gawron VJ. Ocular accommodation, personality, and autonomic balance. Optom Vision Sci. 1983;60:630–639.
    1. Li M, Gong L, Sun X, et al. Anxiety and depression in patients with dry eye syndrome. Curr Eye Res. 2011;36:1–7.
    1. Kaluza G, Maurer H. Stress and intraocular pressure in open angle glaucoma. Psychol Health. 1997;12:667–675.
    1. Pagani M, Mazzuero G, Ferrari A, et al. Sympathovagal interaction during mental stress. A study using spectral analysis of heart rate variability in healthy control subjects and patients with a prior myocardial infarction. Circulation. 1991;83:II43–II51.
    1. Freeman EE, Lesk MR, Harasymowycz P, et al. Maladaptive coping strategies and glaucoma progression. Medicine. 2016;95:e4761.
    1. Çakmak H, Altinyazar V, Yilmaz SG, et al. The temperament and character personality profile of the glaucoma patient. BMC Ophthalmol. 2015;15:125.
    1. Bubella RM, Bubella DM, Cillino S. Type a behavior pattern: is it a risk factor for open-angle chronic glaucoma? J Glaucoma. 2014;23:199–201.
    1. Mabuchi F, Yoshimura K, Kashiwagi K, et al. Personality assessment based on the five-factor model of personality structure in patients with primary open-angle glaucoma. Jpn J Ophthalmol. 2005;49:31–35.
    1. Schinazi VR. Psychosocial implications of blindness and low-vision. CASA Working Papers 114, University College London, UK; 2007.
    1. Carver CS, Connor-Smith J. Personality and coping. Annu Rev Psychol. 2010;61:679–704.
    1. Benn DT. The role of personality traits and coping strategies in late-life adaptation to vision loss. Dissertation, AAI9730084. ETD Collection for Fordham University; 1997.
    1. Tolman J, Hill RD, Kleinschmidt JJ, et al. Psychosocial adaptation to visual impairment and its relationship to depressive affect in older adults with age-related macular degeneration. Gerontologist. 2005;45:747–753.
    1. von Arb M, Gompper B, Meyer AH, et al. Relationship between gender role, anger expression, thermal discomfort and sleep onset latency in women. Bio Psycho Soc Med. 2009;3:11.
    1. Kaluza G, Strempel I. Training in relaxation and visual imagery with patients who have open-angle glaucoma. Int J Rehabil Health. 1995;1:261–273.
    1. Der Schultz-Zehden W. Einfluß psychotherapeutischer Maßnahmen auf die Behandlung des Primärglaukoms. Augenarzt. 1977;11:368–379.
    1. Brennan M, Cardinali G. The use of preexisting and novel coping strategies in adapting to age-related vision loss. Gerontologist. 2000;40:327–34.
    1. Tang YY, Hölzel BK, Posner MI. The neuroscience of mindfulness meditation. Nat Rev Neurosci. 2015;16:213–225.
    1. Pace TWW, Negi LT, Adame DD, et al. Effect of compassion meditation on neuroendocrine, innate immune and behavioral responses to psychosocial stress. Psychoneuroendocrinology. 2009;34:87–98.
    1. Taneja DK. Yoga and health. Indian J Community Med. 2014;39:68.
    1. Stahl JE, Dossett ML, LaJoie AS, et al. Relaxation response and resiliency training and its effect on healthcare resource utilization. PLoS One. 2015;10:e0140212.
    1. Kruzliak P, Sabo J, Zulli A. Endothelial endoplasmic reticulum and nitrative stress in endothelial dysfunction in the atherogenic rabbit model. Acta Histochem. 2015;117:762–766.
    1. Flaten MA, Aslaksen PM, Finset A, et al. Cognitive and emotional factors in placebo analgesia. J Psychosom Res. 2006;61:81–89.
    1. Bushell WC. Longevity. Ann N Y Acad Sci. 2009;1172:20–27.
    1. Schneider RH, Grim CE, Rainforth MV, et al. Stress reduction in the secondary prevention of cardiovascular disease. Circulation: Cardiovasc Qual Outcomes. 2012;5:750–758.
    1. Kurth F, Cherbuin N, Luders E. Promising links between meditation and reduced (brain) aging: an attempt to bridge some gaps between the alleged fountain of youth and the youth of the field. Front Psychol. 2017;8
    1. Backon J, Matamoros N, Ramirez M, et al. A functional vagotomy induced by unilateral forced right nostril breathing decreases intraocular pressure in open and closed angle glaucoma. Br J Ophthalmol. 1990;74:607–609.
    1. Newberg AB, Iversen J. The neural basis of the complex mental task of meditation: neurotransmitter and neurochemical considerations. Med Hypotheses. 2003;61:282–291.
    1. Harte JL, Eifert GH, Smith R. The effects of running and meditation on beta-endorphin, corticotropin-releasing hormone and cortisol in plasma, and on mood. Biol Psychol. 1995;40:251–265.
    1. Jin J, Xu G, Yuan Z. Influence of the hypothalamic arcuate nucleus on intraocular pressure and the role of opioid peptides. PLoS One. 2014;9:e82315.
    1. Sudsuang R, Chentanez V, Veluvan K. Effect of Buddhist meditation on serum cortisol and total protein levels, blood pressure, pulse rate, lung volume and reaction time. Physiol Behav. 1991;50:543–548.
    1. Park J, Lyles RH, Bauer-Wu S. Mindfulness meditation lowers muscle sympathetic nerve activity and blood pressure in African-American males with chronic kidney disease. American journal of physiology-regulatory. Integr Comp Physiol. 2014;307:R93–101.
    1. Tanito M, Kaidzu S, Takai Y, et al. Correlation between systemic oxidative stress and intraocular pressure level. PLoS One. 2015;10:e0133582.
    1. Coca-Prados M, Escribano J. New perspectives in aqueous humor secretion and in glaucoma: the ciliary body as a multifunctional neuroendocrine gland. Prog Retin Eye Res. 2007;26:239–262.
    1. Craigmyle NA. The beneficial effects of meditation: contribution of the anterior cingulate and locus coeruleus. Front Psychol. 2013;4:731.
    1. Rosenkranz MA, Lutz A, Perlman DM, et al. Reduced stress and inflammatory responsiveness in experienced meditators compared to a matched healthy control group. Psychoneuroendocrinology. 2016;68:117–125.
    1. Kemper KJ, Powell D, Helms CC, et al. Loving-kindness meditation’s effects on nitric oxide and perceived well-being: a pilot study in experienced and inexperienced meditators. Explore: J Sci Healing. 2015;11:32–39.
    1. Behar-Cohen FF, Goureau O, D'Hermies F, et al. Decreased intraocular pressure induced by nitric oxide donors is correlated to nitrite production in the rabbit eye. Invest Ophthalmol Vis Sci. 1996;37:1711–1715.
    1. Mohandas E. Neurobiology of spirituality. Mens Sana Monographs. 2008;6:63.
    1. Newberg AB, Wintering N, Khalsa DS, et al. Meditation effects on cognitive function and cerebral blood flow in subjects with memory loss: a preliminary study. J Alzheimers Dis. 2010;20:517–526.
    1. Kaliman P, Álvarez-López MJ, Cosín-Tomás M, et al. Rapid changes in histone deacetylases and inflammatory gene expression in expert meditators. Psychoneuroendocrinology. 2014;40:96–107.
    1. Tang YY, Ma Y, Wang J, et al. Short-term meditation training improves attention and self-regulation. Proc Natl Acad Sci. 2007;104:17152–17156.
    1. Ospina MB, Bond K, Karkhaneh M, et al. Meditation practices for health: state of the research. Evid Rep Technol Assess (Full Rep). 2007;155:1–263.
    1. Wu SD, Lo PC. Inward-attention meditation increases parasympathetic activity: a study based on heart rate variability. Biomed Res. 2008;29:245–250.
    1. Grossman P, Niemann L, Schmidt S, et al. Mindfulness-based stress reduction and health benefits: a meta-analysis. J Psychosom Res. 2004;57:35–43.
    1. Netam R, Yadav RK, Khadgawat R, et al. Interleukin-6, vitamin D & diabetes risk-factors modified by a short-term yoga-based lifestyle intervention in overweight/obese individuals. Indian J Med Res. 2015;141:775.
    1. Sharma P, Poojary G, Dwivedi SN, et al. Effect of yoga-based intervention in patients with inflammatory bowel disease. Int J Yoga Therapy. 2015;25:101–112.
    1. Kemper KJ, Danhauer SC. Music as therapy. Southern Med J. 2005;98:282–288.
    1. Umemura M, Honda K. Influence of music on heart rate variability and comfort. J Hum Ergol. 1998;27:30–38.
    1. White JM. Effects of relaxing music on cardiac autonomic balance and anxiety after acute myocardial infarction. Am J Crit Care. 1999;8:220.
    1. Pelletier CL. The effect of music on decreasing arousal due to stress: a meta-analysis. J Music Ther. 2004;41:192–214.
    1. Knight WEJ, Rickard NS. Relaxing music prevents stress-induced increases in subjective anxiety, systolic blood pressure, and heart rate in healthy males and females. J Music Ther. 2001;38:254–272.
    1. Mckee MG. Biofeedback: an overview in the context of heart-brain medicine. Cleve Clin J Med. 2008;75:S31.
    1. Amore FM, Paliotta S, Silvestri V, et al. Biofeedback stimulation in patients with age-related macular degeneration: comparison between 2 different methods. Can J Ophthalmology/J Can d'Ophtalmologie. 2013;48:431–437.
    1. Moser DK, Dracup K, Woo MA, et al. Voluntary control of vascular tone by using skin-temperature biofeedback-relaxation in patients with advanced heart failure. Altern Ther Health Med. 1997;3:51–59.
    1. Bernat SH, Wooldridge PJ, Marecki M, et al. Biofeedback-assisted relaxation to reduce stress in labor. J Obstet Gynecol Neonatal Nurs. 1992;21:295–303.
    1. Del Pozo JM, Gevirtz RN, Scher B, et al. Biofeedback treatment increases heart rate variability in patients with known coronary artery disease. Am Heart J. 2004;147:545.
    1. Kaluza G, Strempel I. Effects of self-relaxation methods and visual imagery on IOP in patients with open-angle glaucoma. Ophthalmologica. 1995;209:122–128.
    1. Kaluza G, Strempel I, Maurer H. Stress reactivity of intraocular pressure after relaxation training in open-angle glaucoma patients. J Behav Med. 1996;19:587–597.
    1. Bittner AK, Edwards L, George M. Coping strategies to manage stress related to vison loss and fluctuations in retinitis pigmentosa. Optom-J Am Optom Assoc. 2010;81:461–468.
    1. Ben-Zur H, Debi Z. Optimism, social comparisons, and coping with vision loss in Israe. J Visual Impair Blindness. 2005;99:151.
    1. Dreer LE, Elliott TR, Fletcher DC, et al. Social problem-solving abilities and psychological adjustment of persons in low vision rehabilitation. Rehabil Psychol. 2005;50:232.
    1. Garnefski N, Kraaij V, De Graaf M, et al. Psychological intervention targets for people with visual impairments: the importance of cognitive coping and goal adjustment. Disabil Rehabil. 2010;32:142–147.
    1. Bryan JL, Lu Q. Vision for improvement: expressive writing as an intervention for people with Stargardt's disease, a rare eye disease. Journal of Health Psychol. 2016;21:709–719.
    1. Stelmack J. Quality of life of low-vision patients and outcomes of low-vision rehabilitation. Optom Vision Sci. 2001;78:335–342.
    1. Lindenberg RE. Work with families in rehabilitation. Rehabil Couns Bull. 1977;21:(1):67–76.
    1. Moore JE. Impact of family attitudes toward blindness/visual impairment on the rehabilitation process. J Visual Impair Blindness. 1984;78:100–106.
    1. Reinhardt JP. The importance of friendship and family support in adaptation to chronic vision impairment. J Gerontol Ser B Psychol Sci Soc Sci. 1996;51:P268–P278.
    1. Cimarolli VR, Boerner K. Social support and well-being in adults who are visually impaired. J Visual Impair Blindness. 2005;99:521.
    1. Golubnitschaja O, Baban B, Boniolo G, Wang W, Bubnov R, Kapalla M, et al. Medicine in the early twenty-first century: paradigm and anticipation - EPMA position paper 2016. EPMA J. 2016;7:23.
    1. Zhang X, Bullard KMK, Cotch MF, et al. Association between depression and functional vision loss in persons 20 years of age or older in the United States, NHANES 2005-2008. JAMA Ophthalmol. 2013;131:573–581.
    1. Burmedi D, Becker S, Heyl V, et al. I Emotional and social consequences of age-related low vision: a narrative review Visual Impairment Research 2002;4:47–71.
    1. Brennan M. Spirituality and psychosocial development in middle-age and older adults with vision loss. J Adult Dev. 2002;9:31–46.
    1. Rovner BW, Casten RJ, Tasman WS. Effect of depression on vision function in age-related macular degeneration. Arch Ophthalmol. 2002;120:1041–1044.
    1. Wulsin LR, Jacobson AM, Rand LI. Psychosocial correlates of mild visual loss. Psychosom Med. 1991;53:109–117.
    1. Wahl HW, Kämmerer A, Holz F, et al. Psychosocial intervention for age-related macular degeneration: a pilot project. J Visual Impair Blindness. 2006;100:533.
    1. Packwood EA, Cruz OA, Rychwalski PJ, et al. The psychosocial effects of amblyopia study. J Am Assoc Pediatr Ophthalmol Strabismus. 1999;3:15–17.
    1. Rees G, Tee HW, Marella M, et al. Vision-specific distress and depressive symptoms in people with vision impairment. Invest Ophthalmol Vis Sci. 2010;51:2891–2896.
    1. Huurre TM, Aro HM. Psychosocial development among adolescents with visual impairment. Eur Child Adolesc Psychiatry. 1998;7:73–78.
    1. Yochim BP, Mueller AE, Kane KD, et al. Prevalence of cognitive impairment, depression, and anxiety symptoms among older adults with glaucoma. J Glaucoma. 2012;21:250–254.
    1. Erb C, Batra A, Lietz A, et al. Psychological characteristics of patients with normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol. 1999;237:753–757.
    1. Zhou C, Qian S, Wu P, et al. Anxiety and depression in Chinese patients with glaucoma: sociodemographic, clinical, and self-reported correlates. J Psychosom Res. 2013;75:75–82.
    1. Jampel HD, Frick KD, Janz NK, et al. Depression and mood indicators in newly diagnosed glaucoma patients. Am J Ophthalmol. 2007;144:238–244.
    1. Piers G. Glaucoma: the ten-year report 1932–42 Chicago Institute for Psychoanalysis. Quoted in: Alexander F, French TM, eds. Studies in psychosomatic medicine. New York: Ronald; 1948.
    1. Pappa C, Hyphantis T, Pappa S, et al. Psychiatric manifestations and personality traits associated with compliance with glaucoma treatment. J Psychosom Res. 2006;61:609–617.
    1. Eramudugolla R, Wood J, Anstey KJ. Co-morbidity of depression and anxiety in common age-related eye diseases: a population-based study of 662 adults. Front Aging Neurosci. 2013;5:56.
    1. Wang JJ, Mitchell P, Simpson JM, et al. Visual impairment, age-related cataract, and mortality. Arch Ophthalmol. 2001;119:1186–1190.
    1. Scott JA, Egan RA. Prevalence of organic neuro-ophthalmologic disease in patients with functional visual loss. Am J Ophthalmol. 2003;135:670–675.
    1. Hallemani S, Kale M, Gholap M. Level of stress and coping strategies adopted by adolescents with visual impairment. International Journal of Science and Research. 2012;Paper ID:020141262.
    1. Lee PP, Walt JW, Rosenblatt LC, et al. Association between intraocular pressure variation and glaucoma progression: data from a United States chart review. Am J Ophthalmol. 2007;144:901–7.e1.
    1. Rivera JL, Bell NP, Feldman RM. Risk factors for primary open angle glaucoma progression: what we know and what we need to know. Curr Opin Ophthalmol. 2008;19:102–106.
    1. Recupero SM, Contestabile MT, Taverniti L, et al. Open-angle glaucoma: variations in the intraocular pressure after visual field examination. J Glaucoma. 2003;12:114–118.
    1. Lee AJ, Saw SM, Gazzard G, et al. Intraocular pressure associations with refractive error and axial length in children. Br J Ophthalmol. 2004;88:5–7.
    1. Sauerborn G, Schmitz M, Franzen U, et al. Stress and intraocular pressure in myopes. Psychol Health. 1992;6:61–68.
    1. Grom E, Flazs O, Rozen AC. Personality of glaucoma patients as shown by psychological testing. Glaucoma. 1981;3:167–168.
    1. Amihai I, Kozhevnikov M. The influence of Buddhist meditation traditions on the autonomic system and attention. BioMed Research International. 2015.
    1. Erb C, Thiel HJ, Flammer J. The psychology of the glaucoma patient. Curr Opin Ophthalmol. 1998;9:65–70.
    1. Kemeny ME. The psychobiology of stress. Curr Dir Psychol Sci. 2003;12:124–129.
    1. Kloet E. Corticosteroids, stress, and aging. Ann N Y Acad Sci. 1992;663:357–371.
    1. Ritvanen T, Louhevaara V, Helin P, et al. Responses of the autonomic nervous system during periods of perceived high and low work stress in younger and older female teachers. Appl Ergon. 2006;37:311–318.
    1. Gherezghiher T, Hey JA, Koss MC. Parasympathetic nervous control of intraocular pressure. Exp Eye Res. 1990;50:457–462.
    1. Emmerich GM. Psychosomatische Symptome bei rein somatischen Krankheiten unter anderem am Beispiel eines chronischen Offenwinkelglaukoms. Klin Monatsbl Augenheilkd. 2010;227:638–645.
    1. Warrian KJ, Spaeth GL, Lankaranian D, et al. The effect of personality on measures of quality of life related to vision in glaucoma patients. Br J Ophthalmol. 2009;93:310–315.
    1. Beatty S. Non-organic visual loss. Postgrad Med J. 1999;75:201–207.
    1. Werring DJ, Weston L, Bullmore ET, et al. Functional magnetic resonance imaging of the cerebral response to visual stimulation in medically unexplained visual loss. Psychol Med. 2004;34:583–589.
    1. Burggraaff MC, van Nispen RMA, Knol DL, et al. Randomized controlled trial on the effects of CCTV training on quality of life, depression, and adaptation to vision LossRCT on effects of CCTV training. Invest Ophthalmol Vis Sci. 2012;53:3645–3652.
    1. Galvin JA, Benson H, Deckro GR, et al. The relaxation response: reducing stress and improving cognition in healthy aging adults. Complement Ther Clin Pract. 2006;12:186–191.
    1. Vøllestad J, Sivertsen B, Nielsen GH. Mindfulness-based stress reduction for patients with anxiety disorders: evaluation in a randomized controlled trial. Behav Res Ther. 2011;49:281–288.
    1. Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol. 2009;5:374–381.
    1. Matousek RH, Dobkin PL, Pruessner J. Cortisol as a marker for improvement in mindfulness-based stress reduction. Complement Ther Clin Pract. 2010;16:13–19.
    1. Sehgal M. Yoga for health. SENSE. 2011;1(1):322–27.
    1. Haymes S, Guest D, Heyes A, et al. Mobility of people with retinitis pigmentosa as a function of vision and psychological variables. Optom Vision Sci. 1996;73:621–637.
    1. McEwen BS. Stress and hippocampal plasticity. Annu Rev Neurosci. 1999;22:105–122.
    1. Gupta V, Dutta P, Mary OV, et al. Effect of glaucoma on the quality of life of young patients. Invest Ophthalmol Vis Sci. 2011;52:8433–8437.
    1. Weitzman ED, Henkind P, Leitman M, et al. Correlatie 24-hour relationships between intraocular pressure and plasma cortisol in normal subjects and patients with glaucoma. Br J Ophthalmol. 1975;59:566.
    1. Dampney RAL. Central mechanisms regulating coordinated cardiovascular and respiratory function during stress and arousal. Am J Phys Regul Integr Comp Phys. 2015;309:R429–R443.
    1. Nordmann JP, Auzanneau N, Ricard S, et al. Vision related quality of life and topical glaucoma treatment side effects. Health Qual Life Outcomes. 2003;1:75.
    1. Keyworth C, Knopp J, Roughley K, et al. A mixed-methods pilot study of the acceptability and effectiveness of a brief meditation and mindfulness intervention for people with diabetes and coronary heart disease. Behav Med. 2014;40:53–64.
    1. Manchanda SC, Madan K. Yoga and meditation in cardiovascular disease. Clin Res Cardiol. 2014;103:675–680.
    1. Hayman KJ, Kerse NM, La Grow SJ, et al. Depression in older people: visual impairment and subjective ratings of health. Optom Vision Sci. 2007;84:1024–1030.
    1. Méndez-Ulrich JL, Sanz A. Psycho-ophthalmology: contributions of health psychology to the assessment and treatment of glaucoma. Psychol Health. 2017;32:330–342.
    1. Niklewski G. Psychosomatische Erkrankungen des Auges: Eine Übersicht. Z Psychosom Med Psychoanal. 1982:300–16.
    1. Grant P, Seiple W, Szlyk JP. Effect of depression on actual and perceived effects of reading rehabilitation for people with central vision loss. J Rehabil Res Dev. 2011;48:1101.
    1. Barris MC, Kaufman DI, Barberio D. Visual impairment in hysteria. Doc Ophthalmol. 1992;82:369–382.
    1. Khan AO. Severe psychogenic visual loss in a girl with siblings blinded from congenital glaucoma. JAm Assoc Pediatr Ophthalmol Strabismus. 2006;10:373–374.
    1. Taich A, Crowe S, Kosmorsky GS, et al. Prevalence of psychosocial disturbances in children with nonorganic visual loss. J Am Assoc Pediatr Ophthalmol Strabismus. 2004;8:457–461.
    1. Toldo I, Pinello L, Suppiej A, et al. Nonorganic (psychogenic) visual loss in children: a retrospective series. J Neuroophthalmol. 2010;30:26–30.
    1. Cohen SI, Hajioff J. Life events and the onset of acute closed-angle glaucoma. J Psychosom Res. 1972;16:335–341.
    1. Inman WS. Emotion and acute glaucoma. Lancet. 1929;214:1188–1189.
    1. Ripley HS, Wolff HG. Life situations, emotions, and glaucoma. Psychosom Med. 1950;12:215–224.
    1. Grignolo FM, Bongioanni C, Carenini BB. Variations of intraocular pressure induced by psychological stress. Klin Monatsbl Augenheilkd. 1977;170:562.
    1. Weinstein P, Dobossy M. The psychosomatic factors in ophthalmology (author's transl) Klin Monatsbl Augenheilkd. 1975;166:537–539.
    1. Dane ŞE, Kocer I, Demirel H, et al. Effect of acute submaximal exercise on intraocular pressure in athletes and sedentary subjects. Int J Neurosci. 2006;116:1223–1230.
    1. Moschos MM. Physiology and psychology of vision and its disorders: a review. Medical hypothesis, discovery and innovation in. Ophthalmology. 2014;3:83.
    1. Beining G. Zur Psychotherapie des Glaukoms. Psychother Medizin Psychologie. 1951;1:59–63.
    1. Berger AS. The emotional factor in glaucoma: a review. Eye Ear Nose Throat Mon. 1960;39:166–70.
    1. Böhringer HR, Müller C, Meerwein F. Psychiatry of primary glaucoma in relatively younger patients. KlinMonatsbl Augenheilkunde. 1953;123(3):283–302.
    1. Flammer J. Kinderophthalmologie-Auge und Allgemeinerkrankungen. Auge und Psyche. 1999:215–24.
    1. Schultz-Zehden W. Psychosomatische Einflüsse auf das Glaukom. Das autogene Training als unterstützende Therapie. Augenspiegel Heft. 1975;2:2–7.
    1. Abateneh A, Tesfaye M, Bekele S, et al. Vision loss and psychological distress among Ethiopians adults: a comparative cross-sectional study. PLoS One. 2013;8:e78335.
    1. Thurston M, Thurston A, McLeod J. Socio-emotional effects of the transition from sight to blindness. Br J Vis Impair. 2010;28:90–112.
    1. Srees S, Fear NT. Psychosocial impact of visual impairment and coping strategies in female ex-service personnel. J R Army Med Corps. 2016;162:129–133.
    1. Casten RJ, Rovner BW, Tasman W. Age-related macular degeneration and depression: a review of recent research. Curr Opin Ophthalmol. 2004;15:181–183.
    1. Nyman SR, Gosney MA, Victor CR. The psychosocial impact of vision loss on older people. Depression. 2010;2:98.
    1. Carrieri PB, Gentile S, Fusco R, et al. Mood disorders in patients with chronic simple glaucoma. Psychiatry Res. 1991;36:233–235.
    1. Bambara JK, Owsley C, Wadley V, et al. Family caregiver social problem-solving abilities and adjustment to caring for a relative with vision loss. Invest Ophthalmol Vis Sci. 2009;50:1585–1592.
    1. Altangerel U, Spaeth GL, Rhee DJ. Visual function, disability, and psychological impact of glaucoma. Curr Opin Ophthalmol. 2003;14:100–105.
    1. Teoli DA, Smith MD, Leys MJ, et al. Visual function affects prosocial behaviors in older adults. Int Ophthalmol. 2016;36:45–54.
    1. Vu HTV, Keeffe JE, McCarty CA, et al. Impact of unilateral and bilateral vision loss on quality of life. Br J Ophthalmol. 2005;89:360–363.
    1. Keeffe J. Psychosocial impact of vision impairment. Elsevier. 2005;1282:167–173.
    1. Teitelman J, Copolillo A. Psychosocial issues in older adults’ adjustment to vision loss: findings from qualitative interviews and focus groups. Am J Occup Ther. 2005;59:409–417.
    1. Heine C, Browning CJ. Communication and psychosocial consequences of sensory loss in older adults: overview and rehabilitation directions. Disabil Rehabil. 2002;24:763–773.
    1. Datta P. Self-concept and vision impairment: a review. Br J Vis Impair. 2014;32:200–210.
    1. Seybold D. The psychosocial impact of acquired vision loss—particularly related to rehabilitation involving orientation and mobility. Elsevier. 2005;1282:298–301.
    1. Scott IU, Smiddy WE, Schiffman J, et al. Quality of life of low-vision patients and the impact of low-vision services. Am J Ophthalmol. 1999;128:54–62.
    1. Langelaan M, de Boer MR, van Nispen RMA, et al. Impact of visual impairment on quality of life: a comparison with quality of life in the general population and with other chronic conditions. Ophthalmic Epidemiol. 2007;14:119–126.
    1. Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and type D personality. Psychosom Med. 2005;67:89–97.
    1. Lim MC, Shiba DR, Clark IJ, et al. Personality type of the glaucoma patient. J Glaucoma. 2007;16:649–654.

Source: PubMed

3
Předplatit